NCT02484651View on ClinicalTrials.gov

Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 28, 2017

Study Completion Date

July 1, 2017

Conditions
Neuromuscular Block
Interventions
DRUG

Sugammadex

Reversal of deep neuromuscular block

DRUG

Rocuronium

Maintenance of deep neuromuscular block

Trial Locations (1)

4099-001

Centro Hospitalar do Porto, Porto

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Centro Hospitalar do Porto

OTHER

NCT02484651 - Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade? | Biotech Hunter | Biotech Hunter